hyperlipidemia MedDRA version: 6.1 Level: PT Classification code 10020772
Conditions
Interventions
Trade Name: MICARDIS*28CPR 40MG
Pharmaceutical Form: Tablet
INN or Proposed INN: Telmisartan
CAS Number: 144701-48-4
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number:
Sponsors
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: age 18-80 BMI 140 e 90 mmHg e 250 mg/dl Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: renal failure (CK>1.8 mg/dl) epatic failure secondary hypertension secondary hyperlipidemia congestive heart failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: to evaluate the degree of the expression and activity of some molecules likely regulated by the the activation of the RAS system and playing a key role in the early atherosclerosis;Secondary Objective: to evaluate the effect of the AT-1 blocker telmisartan in modulating these molecules in patients with hypercholesterolemia, particularly in terms of response to treatment;Primary end point(s): to evaluate the degree of the expression and activity of some molecules likely regulated by the the activation of the RAS system and playing a key role in the early atherosclerosis | — |
Countries
Italy
Outcome results
None listed